Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

Pioneering Technology Leads to First 3-Tesla, Cryogen-Free MRI Benchtop Scanner

By BiotechDaily International staff writers
Posted on 06 Mar 2013
Print article
Image: The new benchtop 3T MRI scanner (left) located near other laboratory equipment (Photo courtesy of MR Solutions).
Image: The new benchtop 3T MRI scanner (left) located near other laboratory equipment (Photo courtesy of MR Solutions).
Applying technological advances related to supercooling has enabled the development of a superior and more convenient 3-Tesla MRI scanner for biological and medical research laboratories.

The new “3T MRI” benchtop scanner, developed by MR Solutions (Guildford, UK), provides superior soft tissue contrast and molecular imaging capability as well as a breakthrough design that enables it to be conveniently fitted into an existing laboratory.

The scanner includes two major advances. First, the usual MRI liquid helium cooling system has been replaced by using a revolutionary magnet design incorporating new superconducting wire. Through a technology solution pioneered by MR Solutions and its magnet partner, this enables the use of a standard low-temperature cryocooler to cool the magnet to the 4 Kelvin required to achieve superconductivity. Second, the 3T MRI scanner does not require that it be isolated in a “Faraday cage” as its stray magnetic field is only a few centimetres and will not interfere with other equipment in a laboratory. The elimination of the helium cooling system has allowed an optimal installation of an additional solenoid to counter the stray magnetic field. These advances have also dramatically reduced the cost of this powerful scanner to make it highly competitive.

Professor Van der Linden from Bio Imaging Laboratory of the University of Antwerp commented, “This new scanner is a breakthrough and will provide us with the extra scanning power we need within our existing facilities. We can just wheel it in without knocking down any walls and without having to install a costly helium system and the safety system that goes with it. And as its stray magnetic field is so small, we can put other sensitive laboratory equipment and scanners close by for much better work flow.”

Related Links:
MR Solutions



Print article

Channels

Genomics/Proteomics

view channel
Image: Follicular helper T-cells (TFH cells, shown in blue) play a crucial role in the maturation of antibody-producing B-cells (shown in green). Activated B-cells give rise germinal centers (shown in red), where mature B-cells proliferate and produce highly specific antibodies against pathogens. Top left: normal germinal center in a mouse tonsil. All others: Germinal centers fail to form when the interaction between ICOS and TBK1 is interrupted (Photo courtesy of Dr. Kok-Fai Kong, La Jolla Institute for Allergy and Immunology).

Molecular Pathway Controlling High-affinity Antibody Production Identified

A molecular pathway has been identified that controls formation of follicular helper T-cells (TFH cells) germinal centers and production of high-affinity antibodies through interaction with the inducible... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.